Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.
about
Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunitiesCocaine- and opiate-related fatal overdose in New York City, 1990-2000Understanding drug-related mortality in released prisoners: a review of national coronial records.Overdose prevention and naloxone prescription for opioid users in San FranciscoProviding naloxone to substance users for secondary administration to reduce overdose mortality in New York CityA Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. cityOverdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care StaffAttitudes of Emergency Medical Service providers towards naloxone distribution programs.Intranasal naloxone for the treatment of suspected heroin overdose.Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders.Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings.Can naloxone prescription and overdose training for opioid users work in family practice?: Perspectives of family physicians.Prescription opioid abuse: pharmacists' perspective and response.
P2860
Q24678034-448D68EE-54AD-4EC0-B51C-0C15A4DD6E7FQ33277681-149416B7-BE79-42BB-A384-5E830F03366CQ34219932-E7D66E91-E2EF-4578-9C65-BA4C84712C05Q34420178-C75C1492-70CA-47E2-B50E-569A57835A31Q35741203-55534CCF-E3F8-4DD2-9438-84C7760BA0AAQ35751870-09431CB4-6A70-467D-9774-BB4A532972F6Q35923351-D466AB17-0EDF-4514-8064-A6E5013972FFQ35946118-3CDFB756-1B24-427C-BE79-5BB832EABE9DQ36258402-1416AE10-14B0-4A50-AFF6-DD3E92E3A99DQ36274283-44B43F4F-5A73-4D60-B393-1BD3AA2BB1C5Q37082796-0F7083B2-7C22-4D03-8673-BA46C87A079EQ37225942-48DEEB75-1EF6-4F34-A617-CBF153D8F26CQ38931214-FA898509-7637-4CEA-8A71-7FADF4519A4DQ39424322-B8F407AA-61A4-4EC7-AE92-8EE0E57089E4Q40041974-A1F54903-53CD-4DB1-86DD-45A3C23A258AQ40049367-A7FF6EF1-056B-4229-93F0-47DE0DF0E8B5Q46136819-48734FF8-657A-4199-AF86-7BE05D88BE3BQ48078165-EE10A7A1-AD7D-4E49-9B30-8ECA62862AF1
P2860
Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Preliminary evidence of health ...... ion strategy in New York City.
@ast
Preliminary evidence of health ...... ion strategy in New York City.
@en
type
label
Preliminary evidence of health ...... ion strategy in New York City.
@ast
Preliminary evidence of health ...... ion strategy in New York City.
@en
prefLabel
Preliminary evidence of health ...... ion strategy in New York City.
@ast
Preliminary evidence of health ...... ion strategy in New York City.
@en
P2093
P2860
P50
P356
P1476
Preliminary evidence of health ...... tion strategy in New York City
@en
P2093
Crystal Fuller
Liza Vadnai
Shannon Blaney
P2860
P2888
P304
P356
10.1093/JURBAN/JTG031
P577
2003-06-01T00:00:00Z
P5875
P6179
1013834337